Mark Flather | Vice President-Investor Relations |
Shawn Singh | Chief Executive Officer |
Jerry Dotson | Chief Financial Officer |
Brian Skorney | Baird |
Welcome to the VistaGen Therapeutics First Quarter Fiscal Year 2023 Results Conference Call. [Operator Instructions] I’ll now turn the call over to your host, Mark Flather, Vice President of Investor Relations. Mr. Flather, you may begin.
Thank you, Erica.